Researchers have engineered a new enzyme that breaks down nicotine in the bloodstream before it reaches the brain. The treatment reduces the urge to smoke and reverses signs of nicotine dependence, preventing relapse.
Researchers have developed more than a dozen new potential drug candidates they believe have the potential to curb smoking addiction by slowing how nicotine is broken down in the body.
According to a new study, nicotine reduces dorsal striatal output, underlying the urge to smoke and making it difficult to quite the addiction.
Researchers have identified specific chemical changes in the brain that drive nicotine addiction. The findings could lead to new treatments to help break the addiction.
Researchers reveal a surprising association between nicotine addiction and gut bacteria. Gender smoking patterns and the effect nicotine has on a person may be a result of how the gut-brain relationship is impacted by nicotine.
Researchers have identified a genetic variant associated with an increased risk of nicotine dependence.
Researchers are developing a drug that enhances the function of nicotinic acetylcholine receptors. The drug could have three different applications in relieving pain, slowing memory loss in aging people and as a smoking cessation medication.
Study sheds light on how nicotine affects the brains of those with schizophrenia, and why those with the disease tend to be heavy smokers.
A new study opens the door for new treatments to help treat obesity and other eating disorders.
Researchers have crystallized a protein that could hold the answer as to how nicotine addiction occurs in the brain.
Researchers report smoking related deficits in dopamine return to normal three months after quitting.